
A Phase 1b Dose-Escalation Study of Encorafenib (LGX818) and Cetuximab With or Without Alpelisib in Metastatic BRAF -Mutant Colorectal Cancer
van Geel, Robin M.J.M., Tabernero, Josep, Elez, Elena, Bendell, Johanna C, Spreafico, Anna, Schuler, Martin, Yoshino, Takayuki, Delord, Jean-Pierre, Yamada, Yasuhide, Lolkema, Martijn, Faris, Jason E,Langue:
english
Journal:
Cancer Discovery
DOI:
10.1158/2159-8290.CD-16-0795
Date:
March, 2017
Fichier:
PDF, 792 KB
english, 2017